Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification
Table 2
HER2 status results by double immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) on the tissue micros arrays (n = 589 interpretable spots).